Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

Researchers at King's are the first in the world to develop a treatment from a different type of antibody, called IgE. IgE ...

EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as "Tregitopes ...

Recurring infections may signal immune dysfunction. Understanding their cause can improve health and boost your defense ...

A new study from Karolinska Institutet shows how a small antibody fragment can block fertilization by targeting a key protein ...

A new study from Karolinska Institutet shows how a small antibody fragment can block fertilization by targeting a key protein on the surface of the egg.

Study reveals how a new IgE antibody therapy reactivates immune cells, offering a promising approach to fighting ovarian ...

These findings provide mechanistic evidence linking neonatal antibiotic exposure to impaired vaccine immunogenicity via ...

Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.

Researchers at King's are the first in the world to develop a treatment from a different type of antibody, called IgE. IgE has important roles in triggering the immune response during an allergic ...